Provectus Biopharmaceuticals (PVCT) Other Accumulated Expenses (2010 - 2026)
Provectus Biopharmaceuticals' Other Accumulated Expenses came in at $3.16 million for Q2 2026, up 20.4% from $2.62 million a year earlier.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Other Accumulated Expenses (2010 - 2026) Analysis & Trends
Going back to Q4 2010, Provectus Biopharmaceuticals' Other Accumulated Expenses data covers 57 quarters.
- Other Accumulated Expenses carries a five-year compound annual growth rate of 2.6% (FY2020 to FY2025).
- Going back by year, Other Accumulated Expenses was $2.18 million in FY2024 (-32.9%), $3.24 million in FY2023 (+34.8%), $2.4 million in FY2022 (+20.1%) and $2 million in FY2021 (-27.8%).
- The five-year range for quarterly Other Accumulated Expenses is $1.56 million (Q3 2024) to $3.39 million (Q2 2024).
- Year-over-year, Other Accumulated Expenses increased in three of the last seven quarters, with growth averaging 2.0%.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q3 2025 (growth of 81.2%), and the weakest in Q3 2024 (a decline of 49.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.16 Mn |
| Dec 31, 2025 | 3.16 Mn |
| Sep 30, 2025 | 2.82 Mn |
| Jun 30, 2025 | 2.62 Mn |
| Mar 31, 2025 | 2.20 Mn |
| Dec 31, 2024 | 2.18 Mn |
| Sep 30, 2024 | 1.56 Mn |
| Jun 30, 2024 | 3.39 Mn |
| Mar 31, 2024 | 3.10 Mn |
| Dec 31, 2023 | 3.24 Mn |
| Sep 30, 2023 | 3.06 Mn |
| Jun 30, 2023 | 2.88 Mn |
| Mar 31, 2023 | 2.76 Mn |
| Dec 31, 2022 | 2.40 Mn |
| Sep 30, 2022 | 2.44 Mn |
| Jun 30, 2022 | 2.33 Mn |
| Mar 31, 2022 | 2.19 Mn |
| Dec 31, 2021 | 2.00 Mn |
| Sep 30, 2021 | 1.81 Mn |
| Jun 30, 2021 | 1.65 Mn |
API Access
Provectus Biopharmaceuticals Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();